EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:50137 - μ-opioid receptor antagonist
| ChEBI ID | CHEBI:50137 |
| ChEBI Name | μ-opioid receptor antagonist |
| Stars | |
| ASCII Name | mu-opioid receptor antagonist |
| Definition | Any compound that exhibits antagonist activity at the μ-opioid receptor |
| Last Modified | 7 January 2021 |
| Submitter | Marcus Ennis |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| μ-opioid receptor antagonist (CHEBI:50137) is a opioid receptor antagonist (CHEBI:60605) |
| μ-opioid receptor antagonist (CHEBI:50137) is a μ-opioid agent (CHEBI:60599) |
| Incoming Relation(s) |
| levacetylmethadol (CHEBI:6441) has role μ-opioid receptor antagonist (CHEBI:50137) |
| nalbuphine (CHEBI:7454) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxegol (CHEBI:82975) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxone (CHEBI:7459) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxone hydrochloride (CHEBI:31892) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naltrexone (CHEBI:7465) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naltrexone hydrochloride (CHEBI:134687) has role μ-opioid receptor antagonist (CHEBI:50137) |
| β-casomorphin-7 (human) (CHEBI:149635) has role μ-opioid receptor antagonist (CHEBI:50137) |
| Synonyms | Source |
|---|---|
| μ-opioid receptor antagonists | ChEBI |
| μ-opioid antagonist | ChEBI |
| μ-opioid antagonists | ChEBI |